09:25
08:45 Registration
09:25 Welcome remarks
Juliana Chan, Hong Kong
09:30
(supported by Abbott Laboratories Ltd.)
09:30 How do we personalize evidence-based nutritional therapies in diabetes
Katy Wilkens, U.S.A.
10:00 Can good diabetes care prevent osteoporosis and fracture
Elaine Cheung, Hong Kong
10:30 Break
10:45
(supported by Sanofi Hong Kong Ltd.)
10:45 Celebrating insulin 100: Basal Insulin as cornerstone of diabetes treatment
Alice Cheng, Canada
11:15 Timely simultaneous intensification with fixed ratio combination of basal insulin and GLP-1 RA
Ronald Ma, Hong Kong
Symposium 3
11:45
(supported by Merck Pharmaceutical (HK) Ltd.)
11:45 The economic burden of type 2 diabetes in Hong Kong
Rohini Omkar, Singapore
12:15 Trends of diabetes care in Hong Kong – where are the unmet needs
Andrea Luk, Hong Kong
12:45 Lunch break
13:45
(supported by Novo-Nordisk Hong Kong Ltd.)
13:45 Role of incretin-based therapy in COVID-19
Soo Lim, Korea
14:25 Co-formulation of insulin analogues – Review of evidence
Kitty Cheung, Hong Kong
14:45
14:45 Use of metformin in patients with advanced chronic kidney disease
Elaine Chow, Hong Kong
15:15 Vitamins and trace elements in cardiometabolic disease
Kenneth Lo, Hong Kong
15:45 Break
16:00 Smart-phone based lifestyle intervention in gestational diabetes
Tong Wei Yew, Singapore
16:30
16:30 Screening for blood glucose and lipids in a Chinese general population
Martin Wong, Hong Kong
16:45 Role of District Health Centre in prevention of NCD
Jimmy Wu, Hong Kong
17:00 Complexity of diabetes – learning from patients during clinical trials
Andrea Luk & Elaine Chow, Hong Kong
17:20 Panel discussion
17:30 Closing remarks
Andrea Luk, Hong Kong
Made with Mobirise web themes